Prevention, screening, and surveillance care for breast cancer survivors compared with controls

Changes from 1998 to 2002

Claire Snyder, Kevin Frick, Melinda Kantsiper, Kimberly Peairs, Robert J. Herbert, Amanda L. Blackford, Antonio C Wolff, Craig C. Earle

Research output: Contribution to journalArticle

Abstract

Purpose To examine how care for breast cancer survivors compares with controls. Patients and Methods Using the Surveillance, Epidemiology, and End Results-Medicare database, we examined five cohorts of stages 1 to 3 breast cancer survivors diagnosed from 1998 to 2002. For each survivor cohort (defined by diagnosis year), we calculated the number of visits to oncology specialists, primary care providers (PCPs), and other physicians and the percentage who received influenza vaccination, cholesterol screening, colorectal cancer screening, bone densitometry, and mammography during survivorship year 1 (days 366 to 730 postdiagnosis). We compared survivors' care to that of five cohorts of screening controls who were matched to survivors on age, ethnicity, sex, and region and who had a mammogram in the survivor's year of diagnosis and to that of five cohorts of comorbidity controls who were matched on age, ethnicity, sex, region, and comorbidity. We examined whether survivors' care was associated with the mix of physician specialties that were visited. Results A total of 23,731 survivors were matched with 23,731 screening controls and 23,396 comorbidity controls. There was no difference in trends over time in PCP visits between survivors and either control group. The survivors' rate of increase in other physician visits was greater than screening controls (P =.002) but was no different from comorbidity controls. Survivors were less likely to receive preventive care than screening controls but were more likely than comorbidity controls. Trends over time in survivors' care tended to be better than screening controls but were no different than comorbidity controls. Survivors who visited both a PCP and oncology specialist were most likely to receive recommended care. Conclusion Involvement by both PCPs and oncology specialists can facilitate appropriate care for survivors.

Original languageEnglish (US)
Pages (from-to)1054-1061
Number of pages8
JournalJournal of Clinical Oncology
Volume27
Issue number7
DOIs
StatePublished - Mar 1 2009
Externally publishedYes

Fingerprint

Survivors
Breast Neoplasms
Comorbidity
Primary Health Care
Physicians
Bone Neoplasms
Preventive Medicine
Densitometry
Mammography
Medicare
Early Detection of Cancer
Human Influenza
Colorectal Neoplasms
Vaccination
Epidemiology
Survival Rate
Cholesterol
Databases
Control Groups

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Prevention, screening, and surveillance care for breast cancer survivors compared with controls : Changes from 1998 to 2002. / Snyder, Claire; Frick, Kevin; Kantsiper, Melinda; Peairs, Kimberly; Herbert, Robert J.; Blackford, Amanda L.; Wolff, Antonio C; Earle, Craig C.

In: Journal of Clinical Oncology, Vol. 27, No. 7, 01.03.2009, p. 1054-1061.

Research output: Contribution to journalArticle

@article{7e3ea3b4b61b4cc0917e18e8fb56b995,
title = "Prevention, screening, and surveillance care for breast cancer survivors compared with controls: Changes from 1998 to 2002",
abstract = "Purpose To examine how care for breast cancer survivors compares with controls. Patients and Methods Using the Surveillance, Epidemiology, and End Results-Medicare database, we examined five cohorts of stages 1 to 3 breast cancer survivors diagnosed from 1998 to 2002. For each survivor cohort (defined by diagnosis year), we calculated the number of visits to oncology specialists, primary care providers (PCPs), and other physicians and the percentage who received influenza vaccination, cholesterol screening, colorectal cancer screening, bone densitometry, and mammography during survivorship year 1 (days 366 to 730 postdiagnosis). We compared survivors' care to that of five cohorts of screening controls who were matched to survivors on age, ethnicity, sex, and region and who had a mammogram in the survivor's year of diagnosis and to that of five cohorts of comorbidity controls who were matched on age, ethnicity, sex, region, and comorbidity. We examined whether survivors' care was associated with the mix of physician specialties that were visited. Results A total of 23,731 survivors were matched with 23,731 screening controls and 23,396 comorbidity controls. There was no difference in trends over time in PCP visits between survivors and either control group. The survivors' rate of increase in other physician visits was greater than screening controls (P =.002) but was no different from comorbidity controls. Survivors were less likely to receive preventive care than screening controls but were more likely than comorbidity controls. Trends over time in survivors' care tended to be better than screening controls but were no different than comorbidity controls. Survivors who visited both a PCP and oncology specialist were most likely to receive recommended care. Conclusion Involvement by both PCPs and oncology specialists can facilitate appropriate care for survivors.",
author = "Claire Snyder and Kevin Frick and Melinda Kantsiper and Kimberly Peairs and Herbert, {Robert J.} and Blackford, {Amanda L.} and Wolff, {Antonio C} and Earle, {Craig C.}",
year = "2009",
month = "3",
day = "1",
doi = "10.1200/JCO.2008.18.0950",
language = "English (US)",
volume = "27",
pages = "1054--1061",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "7",

}

TY - JOUR

T1 - Prevention, screening, and surveillance care for breast cancer survivors compared with controls

T2 - Changes from 1998 to 2002

AU - Snyder, Claire

AU - Frick, Kevin

AU - Kantsiper, Melinda

AU - Peairs, Kimberly

AU - Herbert, Robert J.

AU - Blackford, Amanda L.

AU - Wolff, Antonio C

AU - Earle, Craig C.

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Purpose To examine how care for breast cancer survivors compares with controls. Patients and Methods Using the Surveillance, Epidemiology, and End Results-Medicare database, we examined five cohorts of stages 1 to 3 breast cancer survivors diagnosed from 1998 to 2002. For each survivor cohort (defined by diagnosis year), we calculated the number of visits to oncology specialists, primary care providers (PCPs), and other physicians and the percentage who received influenza vaccination, cholesterol screening, colorectal cancer screening, bone densitometry, and mammography during survivorship year 1 (days 366 to 730 postdiagnosis). We compared survivors' care to that of five cohorts of screening controls who were matched to survivors on age, ethnicity, sex, and region and who had a mammogram in the survivor's year of diagnosis and to that of five cohorts of comorbidity controls who were matched on age, ethnicity, sex, region, and comorbidity. We examined whether survivors' care was associated with the mix of physician specialties that were visited. Results A total of 23,731 survivors were matched with 23,731 screening controls and 23,396 comorbidity controls. There was no difference in trends over time in PCP visits between survivors and either control group. The survivors' rate of increase in other physician visits was greater than screening controls (P =.002) but was no different from comorbidity controls. Survivors were less likely to receive preventive care than screening controls but were more likely than comorbidity controls. Trends over time in survivors' care tended to be better than screening controls but were no different than comorbidity controls. Survivors who visited both a PCP and oncology specialist were most likely to receive recommended care. Conclusion Involvement by both PCPs and oncology specialists can facilitate appropriate care for survivors.

AB - Purpose To examine how care for breast cancer survivors compares with controls. Patients and Methods Using the Surveillance, Epidemiology, and End Results-Medicare database, we examined five cohorts of stages 1 to 3 breast cancer survivors diagnosed from 1998 to 2002. For each survivor cohort (defined by diagnosis year), we calculated the number of visits to oncology specialists, primary care providers (PCPs), and other physicians and the percentage who received influenza vaccination, cholesterol screening, colorectal cancer screening, bone densitometry, and mammography during survivorship year 1 (days 366 to 730 postdiagnosis). We compared survivors' care to that of five cohorts of screening controls who were matched to survivors on age, ethnicity, sex, and region and who had a mammogram in the survivor's year of diagnosis and to that of five cohorts of comorbidity controls who were matched on age, ethnicity, sex, region, and comorbidity. We examined whether survivors' care was associated with the mix of physician specialties that were visited. Results A total of 23,731 survivors were matched with 23,731 screening controls and 23,396 comorbidity controls. There was no difference in trends over time in PCP visits between survivors and either control group. The survivors' rate of increase in other physician visits was greater than screening controls (P =.002) but was no different from comorbidity controls. Survivors were less likely to receive preventive care than screening controls but were more likely than comorbidity controls. Trends over time in survivors' care tended to be better than screening controls but were no different than comorbidity controls. Survivors who visited both a PCP and oncology specialist were most likely to receive recommended care. Conclusion Involvement by both PCPs and oncology specialists can facilitate appropriate care for survivors.

UR - http://www.scopus.com/inward/record.url?scp=61449116843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449116843&partnerID=8YFLogxK

U2 - 10.1200/JCO.2008.18.0950

DO - 10.1200/JCO.2008.18.0950

M3 - Article

VL - 27

SP - 1054

EP - 1061

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 7

ER -